Esther M John1,2,3, Theresa H Keegan4, Mary Beth Terry5,6, Jocelyn Koo3, Sue A Ingles7, Jenny T Nguyen3, Catherine Thomsen8, Regina M Santella9, Khue Nguyen10, Beizhan Yan10. 1. From the Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA. 2. Department of Medicine (Oncology), Stanford University School of Medicine, Stanford, CA. 3. Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA. 4. Division of Hematology and Oncology, UC Davis Comprehensive Cancer Center, University of California, Davis, CA. 5. Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY. 6. Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY. 7. Department of Population and Public Health Sciences, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA. 8. Zero Breast Cancer, San Rafael, CA. 9. Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY. 10. Lamont Doherty Earth Observatory, Columbia University, Palisades, NY.
Abstract
BACKGROUND: Polycyclic aromatic hydrocarbons (PAHs) are endocrine-disrupting chemicals. Few studies have evaluated the association between pubertal development in girls and PAH exposures quantified by urinary biomarkers. METHODS: We examined associations of urinary PAH metabolites with pubertal development in 358 girls 6-16 years of age from the San Francisco Bay Area enrolled in a prospective cohort from 2011 to 2013 and followed until 2020. Using baseline data, we assessed associations of urinary PAH metabolites with pubertal development stage. In prospective analyses limited to girls who at baseline had not yet started breast (N = 176) or pubic hair (N = 179) development or menstruation (N = 267), we used multivariable Cox proportional hazards regression to assess associations of urinary PAH metabolites with the onset of breast and pubic hair development, menstruation, and pubertal tempo (interval between the onset of breast development and menstruation). RESULTS: We detected PAH metabolites in >98% of girls. In cross-sectional analyses using baseline data, PAH metabolites were not associated with the pubertal development stage. In prospective analyses, higher concentrations (≥ median) of some PAH metabolites were associated with two-fold higher odds of earlier breast development (2-hydroxy naphthalene, 1-hydroxy phenanthrene, summed hydroxy phenanthrenes) or pubic hair development (1-hydroxy naphthalene) among girls overweight at baseline (body mass index-for-age percentile ≥85) compared with nonoverweight girls with lower metabolites concentrations. PAH metabolites were not associated with age at menarche or pubertal tempo. CONCLUSIONS: PAH exposures were widespread in our sample. Our results support the hypothesis that, in overweight girls, PAHs impact the timing of pubertal development, an important risk factor for breast cancer.
BACKGROUND: Polycyclic aromatic hydrocarbons (PAHs) are endocrine-disrupting chemicals. Few studies have evaluated the association between pubertal development in girls and PAH exposures quantified by urinary biomarkers. METHODS: We examined associations of urinary PAH metabolites with pubertal development in 358 girls 6-16 years of age from the San Francisco Bay Area enrolled in a prospective cohort from 2011 to 2013 and followed until 2020. Using baseline data, we assessed associations of urinary PAH metabolites with pubertal development stage. In prospective analyses limited to girls who at baseline had not yet started breast (N = 176) or pubic hair (N = 179) development or menstruation (N = 267), we used multivariable Cox proportional hazards regression to assess associations of urinary PAH metabolites with the onset of breast and pubic hair development, menstruation, and pubertal tempo (interval between the onset of breast development and menstruation). RESULTS: We detected PAH metabolites in >98% of girls. In cross-sectional analyses using baseline data, PAH metabolites were not associated with the pubertal development stage. In prospective analyses, higher concentrations (≥ median) of some PAH metabolites were associated with two-fold higher odds of earlier breast development (2-hydroxy naphthalene, 1-hydroxy phenanthrene, summed hydroxy phenanthrenes) or pubic hair development (1-hydroxy naphthalene) among girls overweight at baseline (body mass index-for-age percentile ≥85) compared with nonoverweight girls with lower metabolites concentrations. PAH metabolites were not associated with age at menarche or pubertal tempo. CONCLUSIONS: PAH exposures were widespread in our sample. Our results support the hypothesis that, in overweight girls, PAHs impact the timing of pubertal development, an important risk factor for breast cancer.
Authors: Mary Beth Terry; Mandy Goldberg; Sarah Schechter; Lauren C Houghton; Melissa L White; Karen O'Toole; Wendy K Chung; Mary B Daly; Theresa H M Keegan; Irene L Andrulis; Angela R Bradbury; Lisa Schwartz; Julia A Knight; Esther M John; Saundra S Buys Journal: Pediatrics Date: 2016-06-08 Impact factor: 7.124
Authors: Gayle C Windham; Raymond Lum; Robert Voss; Mary Wolff; Susan M Pinney; Susan L Teteilbaum; Connie S Sosnoff; Dina Dobraca; Frank Biro; Robert A Hiatt; Louise C Greenspan; Maida Galvez; Lawrence H Kushi Journal: Epidemiology Date: 2017-09 Impact factor: 4.822
Authors: A Mouritsen; L Aksglaede; K Sørensen; S Sloth Mogensen; H Leffers; K M Main; H Frederiksen; A-M Andersson; N E Skakkebaek; A Juul Journal: Int J Androl Date: 2010-04
Authors: Rebecca D Kehm; Sabine Oskar; Parisa Tehranifar; Nur Zeinomar; Andrew G Rundle; Julie B Herbstman; Frederica Perera; Rachel L Miller; Mary Beth Terry Journal: Environ Res Date: 2020-10-22 Impact factor: 6.498
Authors: Mandy Goldberg; Aimee A D'Aloisio; Katie M O'Brien; Shanshan Zhao; Dale P Sandler Journal: Breast Cancer Res Date: 2020-10-27 Impact factor: 6.466